Read the latest NeoGenomics press releases and updates here.

To follow our news, sign up for NeoNEWS, our email newsletter.

August 8, 2019
NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance

July 31, 2019
NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore

July 30, 2019
NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter

July 9, 2019
NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida

July 1, 2019
NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019

June 27, 2019
NeoGenomics Announces New $250 Million Credit Agreement

May 30, 2019
NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference

May 28, 2019
NeoGenomics and QIAGEN Collaborate to Offer Companion Diagnostic Test for HR+/HER2 - Advanced Breast Cancer Patients to Detect a PIK3CA Mutation

May 23, 2019
NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference

May 21, 2019
NeoGenomics Announces Pricing on Public Offering of Common Stock

May 20, 2019
NeoGenomics Announces Proposed Public Offering of Common Stock

April 30, 2019
NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter

April 3, 2019
NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019

April 2, 2019
NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference

March 11, 2019
NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ® ​

March 7, 2019
NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference ​

February 19, 2019
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter​

January 28, 2019
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019

December 13, 2018
NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

December 10, 2018
NeoGenomics Completes Acquisition of Genoptix, Inc.

November 30, 2018
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

October 30, 2018
NeoGenomics Reports 17% Revenue Growth to Record $69 Million

October 23, 2018
NeoGenomics Signs Definitive Agreement to Acquire Genoptix

September 24, 2018
NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

September 12, 2018
NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

August 9, 2018
NeoGenomics Announces Pricing on Public Offering of Common Stock

August 6, 2018
NeoGenomics Announces Proposed Public Offering of Common Stock

July 24, 2018
NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

July 2, 2018
NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

June 25, 2018
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

June 1, 2018
PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

May 25, 2018
NeoGenomics to Participate In Two Upcoming Investor Conferences

May 1, 2018
NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018

April 2, 2018
NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018

March 20, 2018
NeoGenomics Announces Executive Appointments

February 21, 2018
NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017

January 30, 2018
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018

December 31, 2017
NeoGenomics Featured in the Canton of Vaud Annual Report

December 6, 2017
NeoGenomics Announces Six Clinical Data Presentations to be Given at the American Society of Hematology Meeting

December 5, 2017
NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test

November 9, 2017
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

October 25, 2017
NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017

October 24, 2017
NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials

October 12, 2017
NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance

September 28, 2017
NeoGenomics Schedules its Q3 2017 Earnings Release for October 25, 2017

September 11, 2017
NeoGenomics Reports on Impacts from Hurricane Irma

July 25, 2017
NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017

June 28, 2017
NeoGenomics Schedules its Q2 2017 Earnings Release for July 25, 2017

June 2, 2017
NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests

April 26, 2017
NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017

April 20, 2017
NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development

April 14, 2017
NeoGenomics Schedules its Q1 2017 Earnings Release for April 26, 2017

March 13, 2017
NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing

February 22, 2017
NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

February 8, 2017
NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017